Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defect in cholesterol esterification associated with renal diseases.

J Stribrná1, M Dobiásová, V Prát

  • 1Institute for Clinical and Experimental Medicine, Czechoslovak Academy of Sciences, Prague.

International Urology and Nephrology
|January 1, 1987
PubMed
Summary

Patients with chronic kidney disease, including glomerulonephritis and polycystic kidneys, show reduced cholesterol esterification rates. This lipid metabolism change occurs regardless of kidney function, impacting cholesterol balance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.

Physiological research·2017
Same author

Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FER(HDL)) and AIP [log(TG/HDL-C)] biomarkers: the butterfly effect?

Physiological research·2017
Same author

Severe Epidermal Nerve Fiber Loss in Diabetic Neuropathy Is Not Reversed by Long-Term Normoglycemia After Simultaneous Pancreas and Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

[PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2015
Same author

Biomarkers of cardiometabolic risk in obese/overweight children: effect of lifestyle intervention.

Physiological research·2014

Area of Science:

  • Nephrology
  • Lipid Metabolism
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) affects lipid metabolism.
  • Cholesterol esterification is crucial for lipid transport and homeostasis.
  • Understanding lipid changes in CKD can inform patient management.

Purpose of the Study:

  • To investigate alterations in lipidaemia and cholesterol esterification rates in patients with chronic mesangial glomerulonephritis (GN) and polycystic kidney disease (PL).
  • To compare these changes against age- and sex-matched control groups.
  • To assess the relationship between cholesterol esterification and glomerular filtration rate (GFR).

Main Methods:

  • Lipid profiles (cholesterol, triglycerides) were measured.
  • Cholesterol esterification rates, including Molar Esterification Rate (MER) and Fractional Esterification Rate (FER), were determined.

Related Experiment Videos

  • Patients with GN and PL were compared to healthy controls.
  • Analysis included stratification by GFR levels.

    • Main Results:

    • A slight but significant increase in cholesterol and triglyceride concentrations was observed in the GN group compared to controls.
    • A highly significant reduction in cholesterol esterification rates (both MER and FER) was found in both GN and PL patient groups.
    • Patients with low and normal GFR exhibited altered cholesterol esterification and an increased unesterified to esterified cholesterol ratio.

    Conclusions:

    • Patients with chronic glomerulonephritis and polycystic kidney disease exhibit significantly impaired cholesterol esterification.
    • These lipid metabolism disturbances are present even with normal or mildly reduced kidney function.
    • Reduced cholesterol esterification may contribute to dyslipidaemia in chronic kidney disease.